相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway
Xuping Yang et al.
ADIPOCYTE (2020)
SGLT2 Inhibitor Induced Sympathoinhibition A Novel Mechanism for Cardiorenal Protection
Lakshini Y. Herat et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Thermal stress induces glycolytic beige fat formation via a myogenic state
Yong Chen et al.
NATURE (2019)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The effect of dapagliflozin treatment on epicardial adipose tissue volume
Takao Sato et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
Milton Packer
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
Kenneth W. Mahaffey et al.
CIRCULATION (2018)
Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice
Farhana Naznin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2
Vance B. Matthews et al.
JOURNAL OF HYPERTENSION (2017)
Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
Shusuke Yagi et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Dense Intra-adipose Sympathetic Arborizations Are Essential for Cold-Induced Beiging of Mouse White Adipose Tissue
Haochen Jiang et al.
CELL METABOLISM (2017)
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ele Ferrannini
CELL METABOLISM (2017)
Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity
Shiyun Pu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Heart Disease and Stroke Statistics-2016 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2016)
Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES (2016)
The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
Simon A. Hawley et al.
DIABETES (2016)
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes
Giuseppe Daniele et al.
DIABETES CARE (2016)
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
F. Zaccardi et al.
DIABETES OBESITY & METABOLISM (2016)
Sympathetic Neuro-adipose Connections Mediate Leptin-Driven Lipolysis
Wenwen Zeng et al.
CELL (2015)
Brown and Beige Fat: Physiological Roles beyond Heat Generation
Shingo Kajimura et al.
CELL METABOLISM (2015)
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
Linda A. Gallo et al.
DIABETES & VASCULAR DISEASE RESEARCH (2015)
Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance
Jinhan He et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Caroline Bonner et al.
NATURE MEDICINE (2015)
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation
Jieun Lee et al.
CELL REPORTS (2015)
Hypothalamic-autonomic control of energy homeostasis
Patricia Seoane-Collazo et al.
ENDOCRINE (2015)
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
T. Forst et al.
DIABETES OBESITY & METABOLISM (2014)
Neural innervation of white adipose tissue and the control of lipolysis
Timothy J. Bartness et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2014)
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ele Ferrannini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation
Emilio P. Mottillo et al.
JOURNAL OF LIPID RESEARCH (2014)
Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
B. Haas et al.
NUTRITION & DIABETES (2014)
Adult Epicardial Fat Exhibits Beige Features
Harold S. Sacks et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
William T. Cefalu et al.
LANCET (2013)
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Jun Wu et al.
CELL (2012)
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Rudolf Zechner et al.
CELL METABOLISM (2012)
Fatty Acids Change the Conformation of Uncoupling Protein 1 (UCP1)
Ajit S. Divakaruni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models
Yin Liang et al.
PLOS ONE (2012)
Knockdown of NPY Expression in the Dorsomedial Hypothalamus Promotes Development of Brown Adipocytes and Prevents Diet-Induced Obesity
Pei-Ting Chao et al.
CELL METABOLISM (2011)
Targeting thermogenesis and related pathways in anti-obesity drug discovery
John C. Clapham et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Sensory and sympathetic nervous system control of white adipose tissue lipolysis
Timothy J. Bartness et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Antidiabetic agents and cardiovascular risk in type 2 diabetes
Stuart W. Zarich
NATURE REVIEWS ENDOCRINOLOGY (2009)
Adipocytes as regulators of energy balance and glucose homeostasis
Evan D. Rosen et al.
NATURE (2006)
Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation
RJ McCrimmon et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation
Marc Uldry et al.
CELL METABOLISM (2006)
Signalling mechanisms regulating lipolysis
GY Carmen et al.
CELLULAR SIGNALLING (2006)
Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome
Dominique Langin
PHARMACOLOGICAL RESEARCH (2006)
Acute intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei:: Involvement of astrocytes in cerebral glucose-sensing in rats
E Guillod-Maximin et al.
JOURNAL OF NEUROENDOCRINOLOGY (2004)
Native UCP1 displays simple competitive kinetics between the regulators purine nucleotides and fatty acids
IG Shabalina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
T Yamauchi et al.
NATURE MEDICINE (2002)
分享论文
